Analyst Ratings for Intersect ENT (XENT) [Sells]

XENT Rating Summary

XENT Price Target Summary

* Over Last 12-Mos
  |   Expand Research on XENT
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $28.25 (+4.9%) * Over Last 12-Mos
Rating Score: 2.9 / 10   Percentile Rank: 31%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/15/2020 BofA Securities Bob Hopkins Downgrade Underperform
(Buy)
10.00
(28.00)
0.16
(26.94)
16737.5% Details
Like XENT Ratings? Also take a look at MDT, SN, SNN, FCSC

XENT Ratings News